SEGLUROMET 2.5 mg/1 (Ertugliflozin and Metformin Hydrochloride TABLET, FILM COATED) 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for oral use. This medication supports glucose management in adults with type 2 diabetes. Learn about its uses, effects, and precautions.

Strength

2.5 mg/1

Pack Size

500 TABLET, FILM COATED in 1 BOTTLE (0006-5373-07)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Segluromet 2.5 mg/1 is a combination medication used to help manage blood sugar levels in adults with type 2 diabetes. It contains two active ingredients: ertugliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and metformin hydrochloride, a biguanide. Together, they work to lower blood glucose levels. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise.

Side Effects

Common effects of Segluromet 2.5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals may experience urinary tract infections or genital mycotic infections. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Segluromet 2.5 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions like kidney problems or a history of lactic acidosis. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Segluromet 2.5 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. It is also important to be cautious with medications that may cause dehydration or affect electrolyte balance.

Frequently Asked Questions

Segluromet 2.5 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.

Segluromet 2.5 mg/1 should be taken orally, typically with meals, as directed by a healthcare provider.

Common side effects may include nausea, diarrhea, headache, and urinary tract infections.

It is important to consult a healthcare provider before taking Segluromet 2.5 mg/1 with other medications to avoid potential interactions.

Segluromet 2.5 mg/1 may not be suitable for everyone, especially those with certain medical conditions or allergies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.